Patent · US Active

Deuterium-enriched donepezil

US8669275B2 · kind B2 · utility

1Cited by
5References
15Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 3, 2012
Grant dateMar 11, 2014
Priority date
Expiry dateOct 3, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present application describes deuterium-enriched donepezil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.